Condition
B-Cell Non-Hodgkin Lymphoma-Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 3 B-Cell Non-Hodgkin Lymphoma-Recurrent clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest B-Cell Non-Hodgkin Lymphoma-Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JCXH-213 for relapsed or refractory CD19-positive B‑cell non-Hodgkin lymphoma | — | Beijing | Recruiting | Oct 1, 2024 |
| Treatment for relapsed or refractory B-cell non-Hodgkin lymphoma using dual-targeted cells | Phase 1 | Hefei, Anhui and 1 other locations | Recruiting | May 2, 2024 |
| Combining CC-99282 with Rituximab for Non-Hodgkin's Lymphoma Treatment | Phase 1 | Columbus, Ohio | Recruiting | Jan 17, 2024 |
All recruiting trials (3)
-
JCXH-213 for relapsed or refractory CD19-positive B‑cell non-Hodgkin lymphoma
This study will try an in‑body mRNA‑LNP CAR therapy called JCXH-213 in adults with relapsed or refractory CD19-positive B‑cell non‑Hodgkin lymphoma to see if it is safe and can shrink tumors.
-
Treatment for relapsed or refractory B-cell non-Hodgkin lymphoma using dual-targeted cells
This study is testing a new treatment called LUCAR-G39D to see if it can help adults with relapsed or hard-to-treat B-cell non-Hodgkin lymphoma feel better.
-
Combining CC-99282 with Rituximab for Non-Hodgkin's Lymphoma Treatment
This study is testing a new combination of a pill called CC-99282 and an infusion called rituximab to see if it helps people with non-Hodgkin's lymphoma who didn't respond well to previous treatments.
Related topics
Quick answers
How many B-Cell Non-Hodgkin Lymphoma-Recurrent clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.